University of Pittsburgh
Office of Research

 

Material Transfer Agreement (MTA) Frequently Asked Questions (FAQ)

 

Why sign an MTA?
Who signs MTAs?
For-Profit vs Nonprofit MTAs - How are they different?
Do we still need a Cre-Lox license?
What are the common issues that cause delays?
What about compliances?

Why sign an MTA?

Prior to the transfer of material, MTAs address the issues of liability, publication, and intellectual property rights that may result from the research. In addition, concerns such as limits on the use of the materials are frequently included in MTAs. The understanding established by the MTA can help avoid later issues and ensure the collaborative nature of the research.

Who signs MTAs?

The University of Pittsburgh's Office of Research is designated as the office to enter into research contracts on behalf of the University and this includes MTAs. When a researcher signs such an agreement on behalf of the University of Pittsburgh, the researcher could be subjected to legal and financial risks. MTAs, while usually not conveying funding, are still binding documents with possible legal penalties for violations of the terms. It is important for the researcher to read the terms of an MTA before transmitting it for University signature. The Office of Research assumes that a researcher who transmits an MTA has read and agrees to conform to those terms (http://www.pitt.edu/HOME/PP/policies/11/11-01-02.html). The Office of Research will confer with General Counsel and the Office of Technology Management (http://tech-link.tt.pitt.edu/) as required.

For-Profit vs Nonprofit MTAs- How are they different?

The transfer of materials to or from from a nonprofit institution should be as unencumbered as possible. Typically, most universities and nonprofit entities use a simple agreement with few restrictions and agreement is reached expeditiously.

The transfer of materials to or from the for-profit sector is usually more complex, as the corporate entity has an often aggressive interest in protecting its proprietary rights, a stance that can lead to restrictive language in the agreement that the University of Pittsburgh cannot accept. There are also a number of differing contractual formats for transfer of materials from industry, and MTAs can even be called by different names. Therefore, for incoming materials, we must evaluate each case individually and this takes time. For outgoing materials all recipients must use our template.

Do we still need a Cre-Lox license?

The University of Pittsburgh had a Cre-Lox license originally signed in 1997 and updated in 2007. Cre-Lox was a tool developed by DuPont for site-specific recombination of DNA in eukaryotic cells. It regulates the expression of engineered genes at Lox sites through activation of a regulatory sequence that controls the expression of the recombinase Cre gene. Cells can be grown, then turned on, to make the transcript of choice. We have been advised that the US patents for this technology have expired, and use no longer requires a license. Thus the license agreement is terminated.

What are the common issues that cause delays?

  • Submission of incomplete agreements and forms to the University of Pittsburgh's Office of Research:
    • If an MTA is to be submitted in duplicate, we will need two signed original copies. Researchers must sign prior to the Office of Research sign-off.
    • If the MTA requires a research scope to be attached, please attach it for submission.
    • If the MTA requires materials to be filled in, please do so.
      The Office of Research cannot sign incomplete agreements.

  • No contacts provided for negotiation
    If you have the name and e-mail address of a contact person for the other party, please provide this information on the submission form to expedite the process of negotiation.

  • Intellectual property or publication restrictions
    The University will not sign any agreement with “reach through” intellectual property rights or publication restrictions. "Reach through" rights are when a Provider obtains rights to improvements, modifications or inventions made by the researcher in the course of the research, and this can even include royalty or fees paid to the provider. Generally, the NIH requires recipients of federal funds to make research resources available without "reach through" rights.

  • Conflicting contractual obligations
    MTAs that relate to other sponsored agreements or MTAs must be carefully evaluated to ensure that we do not have terms between the multiple documents that conflict with one another. When the terms of an MTA conflict with another agreement, changes will have to be negotiated, and this may cause delay.

  • Governing law outside of Pennsylvania
    The University is a state-related educational institution and cannot sign agreements that are governed outside of Pennsylvania, or out of the US. This also means that most arbitration language cannot be accepted.

  • Warranty or indemnification
    The University is a nonprofit entity and cannot provide warranties for research, results, or materials. We cannot agree to indemnify a sponsor against harm or damages from use of results or materials. The University of Pittsburgh's indemnity is limited to responsibility for our own negligent actions.

  • Compliance
    MTAs undergo compliance review before signing. If you submit an MTA for animals, and you do not include the IACUC approval letter, this will result in a delay in processing as we attempt to obtain that document. The same is true of human subject protocols, hazardous materials, radioactive items and any materials that require approval. Submission of the approval letter with the MTA saves you time.

  • Foreign party involvement, or the transfer of controlled information or technology
    The involvement of these items in an MTA may mean that the document must be reviewed for compliance with US Federal Export Control regulations (http://www.pitt.edu/~offres/ExportControl.html). This is a necessary process to ensure that the University of Pittsburgh remains safely within the fundamental research exemption.

  • Other party unwillingness to negotiate
    Some MTAs are presented as containing non-negotiable language. While the Office of Research is frequently successful in negotiating appropriate language, we cannot negotiate with a party who is unwilling to do so. the Office of Research will make more than one attempt to enter into a dialog, but if the other party is unwilling, our options are quite limited.

What about compliance?

MTAs are contractual documents that are held to the same levels of compliance review (http://www.rcco.pitt.edu/) as a proposal for funding or a grant.

Submission of these approval letters with your MTA will expedite the review process.

8/05, Rev 7/08